NYSE : TFX

Teleflex Incorporated

$133 USD

-$1.98 (-1.47%)

Volume
480.53K
Average Volume
674.07K
Market Capitalization
$5.89B
P/E Ratio
-5.71
Dividend Yield
1.02%
Price Target
$152.50
Year High
$145.00
Year Low
$100.18
Day High
—
Day Low
—
Payout Ratio
-$0.06
Current Ratio
$2.60
Company Overview

NYSE

Jason Weidman

Medical - Instruments & Supplies

Healthcare

TFX

15500

US

USD

https://www.teleflex.com

610 225 6800

879369106

0000096943

Liquidity Metrics

0.99

2.60

2.12

0.42

-0.06

Sales & Valuation

$1.99B

2.26

1.99

15.07

8.97

Profitability

-$20.25

-$905.64M

-39.58%

-15.75%

-31.83%

-15.17%

P/E Metrics

-5.71

-0.30

-0.30

Analyst Price Target & Rating

$152.50

$160.00

$140.00

Sell

2/5

29 Analysts

-12.79%

Financial Health Scores

2.01

5/9

$1.16B

$6.79B

$3.88B

-$339.98M

Key Metrics (TTM)

$8.55B

3.29

-35.91

2.60

-31.83%

1.30%

-17.51%

6.54%

115 days

Company Executives
Name Title
Daniel V. Logue Corporate Vice President, General Counsel & Secretary
John R. Deren Executive Vice President & Chief Financial Officer
Cameron Hicks Corporate Vice President of Human Resources & Communications
Greg Stotts President & GM of Teleflex Medical OEM
Jason Weidman President, CEO & Director
Praneet Mehrotra President of APAC
Stuart A. Randle CEO, Interim President & Director
Howard Cyr Corporate Vice President & Chief Compliance Officer
Jake Newman President & GM of Vascular and Emergency Medicine
James Ferguson President & GM of Surgical
Kevin Robinson President & GM of Anesthesia and Emergency Medicine
Lawrence Soren Keusch Vice President of Investor Relations & Strategy Development
Matthew James President & GM of Interventional
Matt Tomkin Vice President of Corporate Development
Timothy F. Duffy Vice President & Chief Information Officer
Poll Results

No votes yet today — be the first to share your view!

About Teleflex Incorporated (NYSE:TFX) Stock

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural hea ... rt conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

TFX vs. PEN: Which Stock Is the Better Value Option?

2026-08-10 12:41:08

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?

Why Teleflex (TFX) International Revenue Trends Deserve Your Attention

2026-08-10 10:16:24

Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Teleflex Q2 Earnings Call Highlights

2026-08-09 06:04:34

Teleflex NYSE: TFX reported second-quarter revenue and adjusted earnings above its expectations, supported by strong growth in its Vascular and Surgical businesses, while slower-than-anticipated integration of its acquired Vascular Intervention business weighed on Interventional results.

Teleflex Incorporated (TFX) Q2 2026 Earnings Call Transcript

2026-08-06 12:14:21

Teleflex Incorporated (TFX) Q2 2026 Earnings Call Transcript

Teleflex (TFX) Reports Q2 Earnings: What Key Metrics Have to Say

2026-08-06 10:31:19

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Teleflex (TFX) Surpasses Q2 Earnings and Revenue Estimates

2026-08-06 09:21:12

Teleflex (TFX) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $3.73 per share a year ago.

Teleflex Announces Quarterly Dividend

2026-08-06 06:45:00

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 30, 2026, to shareholders of record at the close of business on August 14, 2026. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to bec.

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

2026-08-06 06:30:00

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 30, 2026. Second quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $570.3 million, up 28.9% compared to the prior year period, and up 4.7% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $0.96, compared to $1.54 in the prior year period Adjusted diluted EPS fr.

Frequently Asked Questions

What is the current Teleflex Incorporated (TFX) stock price?

Teleflex Incorporated(NYSE:TFX) stock price is $133 in the last trading session. During the trading session, TFX stock reached the peak price of $145 while $100.18 was the lowest point it dropped to. The percentage change in TFX stock occurred in the recent session was --1.47% while the dollar amount for the price change in TFX stock was -$1.98.

TFX's industry and sector of operation?

The NYSE listed TFX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of TFX?

Daniel V. Logue | Corporate Vice President, General Counsel & Secretary
John R. Deren | Executive Vice President & Chief Financial Officer
Cameron Hicks | Corporate Vice President of Human Resources & Communications
Greg Stotts | President & GM of Teleflex Medical OEM
Jason Weidman | President, CEO & Director

How many employees does TFX have?

Number of TFX employees currently stands at 15500. TFX operates from 550 East Swedesford Road, Wayne, PA 19087-1603, US.

Link for TFX official website?

Official Website of TFX is: https://www.teleflex.com

How do I contact TFX?

TFX could be contacted at phone #610 225 6800 and can also be accessed through its website. TFX operates from 550 East Swedesford Road, Wayne, PA 19087-1603, US.

How many shares of TFX are traded daily?

The average number of TFX shares traded daily for last 3 months was 674.07K.

What is the market cap of TFX currently?

The market value of TFX currently stands at $5.89B with its latest stock price at $133